Preface
A second look at the ancient drug: new insights into metformin
Annals of Translational Medicine
2014;
2
(6)
:51
.
(27 June 2014)
Editorial
Metformin and the risk of cancer in Type 2 diabetes: methodological challenges and perspectives
Annals of Translational Medicine
2014;
2
(6)
:52
.
(27 June 2014)
Metformin: good or bad for the brain?
Annals of Translational Medicine
2014;
2
(6)
:53
.
(27 June 2014)
Metformin in the diabetic brain: friend or foe?
Annals of Translational Medicine
2014;
2
(6)
:54
.
(27 June 2014)
Review Article
Impact of metformin on reproductive tissues: an overview from gametogenesis to gestation
Annals of Translational Medicine
2014;
2
(6)
:55
.
(27 June 2014)
Metformin use in women with polycystic ovary syndrome
Annals of Translational Medicine
2014;
2
(6)
:56
.
(27 June 2014)
Metformin in cancer prevention and therapy
Annals of Translational Medicine
2014;
2
(6)
:57
.
(27 June 2014)
microRNAs and cancer metabolism reprogramming: the paradigm of metformin
Annals of Translational Medicine
2014;
2
(6)
:58
.
(27 June 2014)
Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumorassociated miRNAs in breast and pancreatic cancers
Annals of Translational Medicine
2014;
2
(6)
:59
.
(27 June 2014)
Do metformin a real anticarcinogen? A critical reappraisal of experimental data
Annals of Translational Medicine
2014;
2
(6)
:60
.
(27 June 2014)
Disclosure:
The focused issue“New insights into metformin” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding. Min Shen served as the unpaid Guest Editor for the focused issue.